GigaGen, Inc
- Biotech or pharma, therapeutic R&D
GigaGen, a subsidiary of Grifols, is a clinical-stage biopharmaceutical company with a best-in-class antibody discovery platform and novel therapies for patients with cancer, infectious disease, and other life-threatening illnesses. GIGA-564 is our differentiated T reg depleter in clinical development available for partnering.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}